beta
Trial Radar AI
Clinical Trial NCT06515873 (SILVR) for Virtual Reality, Spinal Anesthesia is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View

Seniors' Intraoperative Management Under Locoregional Anesthesia Integrating Virtual Reality (SILVR) 55 Senior-Focused Virtual

Not yet recruiting
Clinical Trial NCT06515873 (SILVR) is an interventional study for Virtual Reality, Spinal Anesthesia and is currently not yet recruiting. Enrollment is planned to begin on 1 July 2024 and continue until the study accrues 55 participants. Led by Ciusss de L'Est de l'Île de Montréal, this study is expected to complete by 1 March 2025. The latest data from ClinicalTrials.gov was last updated on 23 July 2024.
Brief Summary
This study aims to evaluate the acceptability of intraoperative virtual reality in elderly patients under spinal anesthesia.
Detailed Description
For the past decade, virtual reality (VR) has been expanding across various medical applications fields. Regarding surgery and anesthesia, VR was used during different procedures such as orthopedics surgery of the upper extremities under regional anesthesia blocks, hip and knee arthroplasties, dental care and induction of anesthesia, especially in pediatrics. Using VR during surgery can reduce pain, anxiety, quantity...Show More
Official Title

Evaluating the Acceptability of Virtual Reality Headsets During Surgery Under Spinal Anesthesia in Elderly Patients. Seniors' Intraoperative Management Under Locoregional Anesthesia Integrating Virtual Reality (SILVR)

Conditions
Virtual RealitySpinal Anesthesia
Publications
Scientific articles and research papers published about this clinical trial:
Other Study IDs
  • SILVR
  • 2025-3770
NCT ID Number
Start Date (Actual)
2024-07
Last Update Posted
2024-07-23
Completion Date (Estimated)
2025-03
Enrollment (Estimated)
55
Study Type
Interventional
PHASE
N/A
Status
Not yet recruiting
Keywords
Elderly patient
Acceptability
Primary Purpose
Supportive Care
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
Participant Group/ArmIntervention/Treatment
Experimentala group of 55 patients
Virtual Reality Headset
The virtual reality headset, which will display one of the 3 available scenarios, will be placed on the patient head during a surgery under spinal anesthesia.
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Patient's tolerance to headset
The primary endpoint is the patient's tolerance to virtual reality defined by the headset to be worn for more than or equal to 30 minutes by the participant
Intraoperative (from T0 = the patient puts on the headset until Tend = 30 minutes after T0)
Secondary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
Anxiety before the surgery
Level of anxiety before the surgery evaluated by the Amsterdam Preoperative Anxiety and Information Scale (a scale from 1 - not at all to 5 - extremely, 6 questions).
preoperative (from T0 = the patient arrives at the hospital the morning of the surgery until Tend = the patient enters the operating room, about 2 hours)
Total of time before the patient's first request to interrupt the experiment
The total time in minutes, both in absolute and relative to the duration of the surgery, from the start of the initially chosen scenario to the first request to interrupt the experiment.
intraoperative (from T0 = the patient puts on the headset at the beginning of the surgery until Tend = the patient first asks to interrupt the experiment during the surgery, about 45 minutes - depending on the person and the surgery)
Total of time during which the patient wears the VR headset during surgery.
The total time in minutes, both in absolute and relative to the duration of the surgery, from the start of the initially chosen scenario to the headset removal
intraoperative (from T0 = the patient puts on the headset and starts the initially chosen scenario until Tend = the patient takes off the headset, about 45 minutes - depending on the person and the surgery)
Time spent on each scenario and the order in which they were presented
Compare the total duration in minutes the patient wore the headset depending on the type of scenario chosen, and the order in which they were presented
intraoperative (from T0 = the patient starts the first scenario until Tend = he asks to change the scenario) - for each scenario, about 45 minutes - depending on the person and the surgery
Incidence of adverse effects
The incidence of adverse effects such as cybersickness, as reported by the patient
intraoperative (from T0 = the patient puts on the headset until Tend = the patient takes off the headset, about 45 minutes - depending on the surgery)
Patient's satisfaction
The satisfaction, ease to use the VR and main complaints of the participant, assessed through interviews using semi-standardized questions (17 open questions during a discussion, transcribe verbatim, to make a qualitative analysis)
postoperative (from T0 = the surgery ends until Tend = the semi-structured questionnaire is over, about 2 hours)
Participation Assistant
Eligibility Criteria

Eligible Ages
Older Adult
Minimum Age
65 Years
Eligible Sexes
All
  • Fully consented patients over 65 years old
  • Undergoing elective surgery that requires spinal anesthesia.

  • Hearing or visual impairment
  • History of epilepsy, seizure, or severe dizziness
  • Severe mental impairment
  • Recent eye or facial surgery or wounds
  • Inability to use their hands
Ciusss de L'Est de l'Île de Montréal logoCiusss de L'Est de l'Île de Montréal
Study Responsible Party
Pascal Laferrière-Langlois, Principal Investigator, MD, MSc, FRQS, Assistant Professor, Principal Investigator, Anesthesiologist, Ciusss de L'Est de l'Île de Montréal
Study Central Contact
Contact: Pascal Laferrière-Langlois, +1-819-432-5847, [email protected]
Contact: Nadia Godin, 514-252-3400, [email protected]
1 Study Locations in 1 Countries

Quebec

Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal, Montreal East, Quebec, H1T2M4, Canada